Here is the latest stock price and chart of Dishman Pharma. For more details, see the Dishman Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
10 Charts, 1 Growth Story: Join us for an Exclusive Webinar LIVE on April 23rd @6pm
Live BSE Quotes | May 29, 2017 (Close) | ||
---|---|---|---|
Price (Rs)301.05 | Open (Rs) 293.00 | High (Rs) 304.30 | Low (Rs) 278.10 |
% Change2.87 | Volume 460,499 | Value (Rs) 135,767,416 | 52-Week H/L 346.25 / 127.60 |
Live NSE Quotes | Apr 20, 2021 3:29:49 PM | ||
---|---|---|---|
Price (Rs)160.00 | Open (Rs) 161.50 | High (Rs) 169.00 | Low (Rs) 155.65 |
% Change3.93 | Volume 105,957 | Value (Rs) 17,221,191 | 52-Week H/L 347.00 / 127.95 |
Change | |||||
---|---|---|---|---|---|
1 Day 2.87% | 1 Month -2.45% | 3 Months 30.49% | 1 Year 96.38% | 5 Years (CAGR)* 62.16% | 10 Years (CAGR)* 9.41% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 12.00 | P/E Ratio (x) 25.09 | Market Cap (Rs m) 48,587.66 | P/BV (x) 3.35 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
![]() |
||
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DISHMAN PHARMA last traded price was up 3.9% to Rs 160.0 on the NSE. The total volume of shares traded was 0.1 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.2%. And the benchmark NIFTY 50 was at 14,279.6 (down 0.6%).
Over the last 30 days, the DISHMAN PHARMA share price is down 48.3%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
Sorry! There are no related views on news for this company/sector.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
Those who don't learn from financial history are doomed to lose their money.
More